Core Viewpoint - The approval of the spinal surgery robot and related intelligent products by the National Medical Products Administration marks a significant milestone for the company and its innovation strategy in the medical device sector [1][2]. Group 1: Product Development - The spinal surgery robot, named the spinal surgical navigation positioning system, integrates advanced technologies such as multi-arm robotic systems, lightweight medical-grade mechanical structures, electromagnetic navigation, and optical imaging [1]. - The new generation of surgical robots aims to enhance AI intelligence, enabling clinical doctors to perform surgeries more accurately and safely, with customizable solutions based on specific surgical needs [1]. Group 2: Market Impact - The approval of the product for the innovative channel is a key milestone in the company's innovation research and development system, contributing to its growth strategy [2]. - The company’s other subsidiary, Suzhou Yunhejing, has also developed a "surface porous polyether ether ketone interbody fusion device," which is expected to enter the innovative channel by April 2025, further enhancing the company's product offerings [2].